BDBM256563 US10435361, Example 62::US9481648, 62::US9790174, Example 62

SMILES: COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C

InChI Key: InChIKey=WYWRLMHPIIOOOI-UHFFFAOYSA-N

Data: 12 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 256563   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	32	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description Method 2: This method follows the same steps as Method 1 above, but utilises a higher concentration of the p38 MAPKα protein (2.5 uL of 200 ng/...				US Patent US9481648 (2016) BindingDB Entry DOI: 10.7270/Q24F1PNH
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	44	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9481648 (2016) BindingDB Entry DOI: 10.7270/Q24F1PNH
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.32E+3	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9481648 (2016) BindingDB Entry DOI: 10.7270/Q24F1PNH
					More data for this Ligand-Target Pair
Glycogen synthase kinase-3 (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.06E+4	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description Method 2: This method follows the same steps as Method 1 above, but utilises a shorter period of mixing of the test compound (105 minutes instead of ...				US Patent US9481648 (2016) BindingDB Entry DOI: 10.7270/Q24F1PNH
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	32	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The following two assay variants can be used for determination of p38 MAPKα inhibition.Method 1The inhibitory activities of test compounds again...				US Patent US9790174 (2017) BindingDB Entry DOI: 10.7270/Q2M61NCF
					More data for this Ligand-Target Pair
Glycogen synthase kinase-3 (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.06E+4	n/a	n/a	n/a	n/a	n/a	n/a
Topivert Pharma Limited US Patent					Assay Description TBD				US Patent US10435361 (2019) BindingDB Entry DOI: 10.7270/Q25M6839
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.32E+3	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9790174 (2017) BindingDB Entry DOI: 10.7270/Q2M61NCF
					More data for this Ligand-Target Pair
Glycogen synthase kinase-3 (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.06E+4	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level o...				US Patent US9790174 (2017) BindingDB Entry DOI: 10.7270/Q2M61NCF
					More data for this Ligand-Target Pair
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	32	n/a	n/a	n/a	n/a	n/a	n/a
Topivert Pharma Limited US Patent					Assay Description TBD				US Patent US10435361 (2019) BindingDB Entry DOI: 10.7270/Q25M6839
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	44	n/a	n/a	n/a	n/a	n/a	n/a
Topivert Pharma Limited US Patent					Assay Description TBD				US Patent US10435361 (2019) BindingDB Entry DOI: 10.7270/Q25M6839
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.32E+3	n/a	n/a	n/a	n/a	n/a	n/a
Topivert Pharma Limited US Patent					Assay Description TBD				US Patent US10435361 (2019) BindingDB Entry DOI: 10.7270/Q25M6839
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM256563 (US10435361, Example 62 | US9481648, 62 | US9790174...) Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	44	n/a	n/a	n/a	n/a	n/a	n/a
Respivert Limited; Topivert Pharma Limited US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9790174 (2017) BindingDB Entry DOI: 10.7270/Q2M61NCF
					More data for this Ligand-Target Pair